Orthofix Medical (OFIX)
(Delayed Data from NSDQ)
$15.29 USD
+0.04 (0.26%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $15.30 +0.01 (0.07%) 6:12 PM ET
4-Sell of 5 4
C Value C Growth B Momentum B VGM
Price, Consensus and EPS Surprise
OFIX 15.29 +0.04(0.26%)
Will OFIX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for OFIX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for OFIX
Zimmer Biomet's (ZBH) Latest Deal to Expand Its Hip Portfolio
Orthofix (OFIX) Surpasses Q2 Earnings and Revenue Estimates
OFIX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Orthofix Medical's (OFIX) Fitbone System Gets FDA Clearance
Orthofix Medical's (OFIX) Telescopic Nail Gets FDA Clearance
Avanos Medical (AVNS) Q1 Earnings Beat Estimates (Revised)
Other News for OFIX
Orthofix Highlights New Products and Announces Presentation of Data Supporting the Adjunct Use of Bone Growth Therapy for Lumbar Spine Fusion at North American Spine Society Annual Meeting
Needham medtech & diagnostics analyst holds analyst/industry conference call
Needham medtech & diagnostics analyst holds analyst/industry conference call
Levi & Korsinsky LLP Notifies Orthofix Medical Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – OFIX
Patrick Fisher Joins Orthofix as President of Global Orthopedics Business